Skip to main content
TVTX logo

TVTX

Travere Therapeutics, Inc.

$56.74

0.56%

Trade Ideas Performance

Latest Closed Trade Idea

$56.74

0.56%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

1

Social

12

About

Events of Travere Therapeutics, Inc. (TVTX)

Several events have impacted Travere Therapeutics' stock price over the past six months. The full FDA approval for FILSPARI in FSGS led to a stock increase. The Q1 2026 earnings report showed a loss per share but an adjusted net income that beat analyst estimates. The Q4 2025 earnings report met analyst expectations. An FDA request for additional data caused a pre-market stock drop. The Q3 2025 earnings report resulted in a stock surge. Overall, the share price increased significantly between May 5, 2025, and May 1, 2026.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Travere Therapeutics, Inc. (TVTX) Live Stock Price, Chart & Financial News | Edge Hound